Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2023
Filter by date:
Showing 1262 press releases before 2023
-
MedImmune and Cancer Research UK establish joint CRUK-MEDI Alliance Laboratory to develop new biologic cancer medicines
-
MedImmune receives fast track designation from FDA for development of MEDI3902 for prevention of nosocomial pneumonia
-
Study showed AstraZeneca’s exenatide once-weekly suspension for autoinjection provided superior HbA1c reductions vs. twice-daily exenatide (Byetta®) in adults with type 2 diabetes
-
FDA approves MOVANTIK™ (naloxegol) tablets C-II for the treatment of opioid-induced constipation in adult patients with chronic non-cancer pain
-
AstraZeneca and Lilly announce alliance to develop and commercialise BACE inhibitor AZD3293 for Alzheimer’s disease
-
AstraZeneca to present research from its innovative diabetes portfolio at the 2014 Meeting of the European Association for the Study of Diabetes
-
Benralizumab Phase II COPD study published in The Lancet Respiratory Medicine
-
AstraZeneca and Redx Pharma agree research collaboration targeting genetic drivers of tumour growth
-
New data indicates Brilinta/Brilique™ has the flexibility to be initiated pre-hospital or in hospital in STEMI patients
-
AstraZeneca announces partnership with Illumina to develop next generation gene sequencing panel for companion diagnostic tests
Latest articles and press releases
All of our latest press releases and articles are available to explore
Use a maximum of two downloads here
